World Journal of Emergency Medicine, 2021, 12(3): 198-201 doi: 10.5847/wjem.j.1920-8642.2021.03.006

Original Articles

Optimized strategy of rotational atherectomy of underexpanded coronary stents in patients with acute coronary syndrome

Kun Cui1, You-quan Shi2, Yuan-zheng Zhang3, Zheng-gong Li1, Chang-ling Li,4

1 Department of Cardiology, Chongqing General Hospital, Chongqing 400013, China

2 Department of Cardiology, the Third People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830000, China

3 Department of Cardiology, the First People’s Hospital of Tianshui, Tianshui 741000, China

4 Department of Cardiology, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China

Corresponding authors: Chang-ling Li, Email:lichali@zju.edu.cn

Received: 2020-12-15   Accepted: 2021-03-10   Online: 2021-07-1

Abstract

BACKGROUND: Stent under-expansion is a main cause of acute coronary syndrome (ACS), which can lead to serious clinical outcomes. The rotational atherectomy of underexpanded coronary stents (academically called stent ablation, SA) by intravascular ultrasound (IVUS) may provide more visual reference in the intervention. We aim to analyze the procedural and long-term outcomes of the optimized strategy of SA in patients with ACS and to provide real-world data on this technique.

METHODS: A total of 11 patients with ACS who underwent SA between April 2017 and January 2019 were analyzed. Clinical follow-ups were obtained either by telephone call or by scheduled visit. Clinical end-points included periprocedural and postprocedural myocardial infarction, stent thrombosis, target lesion revascularization, and major adverse cardiac events.

RESULTS: The mean age of patients was 69.6±6.5 years, and five (45.5%) patients were males. All cases presented with unstable angina and were admitted with ACS. All patients required at least two burrs during the intervention and the size of the burr was selected based on the data of minimum lumen diameter (MLD), and the first and the second burr/stent MLD ratios were 0.93 (0.88-0.99) and 1.09 (1.02-1.14), respectively. Nine patients were treated with drug-eluting stents and two were treated with drug-coated balloons. There were no complications including no flow, perforation, or burr entrapment during the intervention. No in-hospital deaths or major adverse cardiac events were documented during the follow-up period. In our study, less contrast agent and a lower dose of radiation were used during the intervention.

CONCLUSIONS: SA guided by IVUS can reduce the risk of complications, assess the results of surgery, inform the selection of stent size, and decrease the required dose of radiation and contrast.

Keywords: Acute coronary syndrome; Intravascular ultrasound; Rotational atherectomy; Underexpanded stent

PDF (234KB) Metadata Metrics Related articles Export EndNote| Ris| Bibtex  Favorite

Cite this article

Kun Cui, You-quan Shi, Yuan-zheng Zhang, Zheng-gong Li, Chang-ling Li. Optimized strategy of rotational atherectomy of underexpanded coronary stents in patients with acute coronary syndrome. World Journal of Emergency Medicine, 2021, 12(3): 198-201 doi:10.5847/wjem.j.1920-8642.2021.03.006

INTRODUCTION

Over the last decade, the number of percutaneous coronary intervention (PCI) procedures in China has increased more than 20 folds, with 454,505 procedures reported in 2013.[1,2] However, due to the incomplete application of intravascular ultrasound (IVUS) or optical coherence tomography (OCT), many surgeons perform insufficient examination of calcification and dense fibrous plaques of the lesion. In clinical practice, less application of rotatory technique, scoring balloon, or cutting balloon leads to poor pretreatment of lesions. Poor stent expansion has an impact on stent thrombosis and restenosis, which always leads to acute coronary syndrome (ACS). It will reduce the occurrence of ACS if we could effectively treat calcified coronary lesions.[3]

One study showed that among all lesions evaluated by angiography, the incidence of calcified coronary lesions was 38%, and this number was 74% in cases that received IVUS.[4] Rotational atherectomy (RA) has been used as an alternative to the treatment of irreparable calcified lesions, usually with good long-term effects before stent deployment.[5,6] This suggests that RA may be used in underexpanded stent patients with ACS. Through IVUS evaluation of lesions during surgery, information such as vascular calcification, stent swelling, minimum lumen diameter (MLD), and area can be accurately obtained, which provides reliable guidance for subsequent stent rotation.[7,8,9,10] At present, studies on rotational atherectomy of underexpanded coronary stents (academically called stent ablation, SA) in patients with ACS are limited to case reports and small-center retrospective analysis. The purpose of this study is to analyze SA in patients with ACS as an effective alternative strategy for treating underexpanded stents.

METHODS

Study population

Patients with ACS, who underwent SA in the Second Affiliated Hospital of Zhejiang University School of Medicine for intrastent restenosis due to coronary stent under-expansion between April 2017 and January 2019, were analyzed. All patients had symptomology of unstable angina and previously received high-pressure noncompliant balloon inflation. All patients signed informed consent forms for the procedure and usage of their medical data for research purposes.

Interventional procedure

Patients were pretreated with dual-antiplatelet therapy before the procedure and the treatment lasted for at least 12 months after the procedure. The RotaLinkPlus system (Boston Scientific, Marlborough, USA) and a standard 0.009-inch guidewire (RotaWire; Boston Scientific, Marlborough, USA) were used to perform SA. Rotational speed was set between 170,000 to 200,000 r/min and all ablation time was less than 15 seconds to prevent risk of thrombosis due to excessive thermal injury. IVUS during the whole operation was needed to obtain information about the health condition of original stent, minimum lumen area (MLA), MLD, effect of SA, and the length of stent that needed to be implanted.

Definitions and follow-up

Procedural success was defined as the successful SA of the underexpanded stent and successful delivery of an adequately apposed stent with residual stenosis <30%. Major adverse cardiac events (MACEs) were defined as the composite of death, myocardial infarction, and target vessel revascularization (TVR) events. ACS was defined as recurrent symptoms of unstable angina with new re-elevation of cardiac markers to at least twice the upper limit of normal.[11,12] Clinical follow-ups were obtained either by telephone call or by scheduled visit. Clinical end-points included periprocedural and postprocedural myocardial infarction, stent thrombosis, target lesion revascularization, and MACEs. Continuous variables were presented as mean±standard deviation (SD) or median (interquartile range) and categorical data as numbers and percentages.

RESULTS

The main baseline demographic data of the 11 patients are shown in Table 1. Important prevalence of cardiovascular risk factors was found among them. The median left ventricular ejection fraction was 52.3% (45.5%-60.2%) and the median glomerular filtration rate was 67 (43-78) mL/minute.

Table 1   Baseline characteristics

ParametersResults
Age, years69.6±6.5
Male, n (%)5 (45.5)
Hypertension, n (%)9 (81.8)
Dyslipidemia, n (%)4 (36.4)
Diabetes, n (%)7 (63.6)
Previous CABG, n (%)0 (0)
Left ventricular ejection fraction, %52.3 (45.5-60.2)
Glomerular filtration rate, mL/min67 (43-78)
Indication for PCI, n (%)
NSTEMI10 (90.9)
STEMI1 (9.1)

CABG: coronary artery bypass grafting; PCI: percutaneous coronary intervention; NSTEMI: non-ST-segment elevation myocardial infarction; STEMI: ST-segment elevation myocardial infarction.

New window| CSV


The procedural characteristics are shown in Table 2. The clinical outcomes are shown in Table 3. There were no complications including no flow, perforation, or burr entrapment during the interventions. However, vasoactive drugs were needed in two patients because of transient hemodynamic instability.

Table 2   Procedural characteristics

ParametersResults
DES-ISR/BMS-ISR, n (%)10 (90.1) /1 (9.1)
Calcification, n (%)9 (81.8)
Coronary artery treated, n (%)
LM0 (0)
LAD7 (63.6)
LCX1 (9.1)
RCA3 (27.3)
Pre-SA stent MLD/stent ratio0.64 (0.60-0.66)
Pre-SA stent MLA, mm22.58 (2.03-4.26)
Burr/stent ratio
First burr/stent ratio0.93 (0.88-0.99)
Second burr/stent ratio1.09 (1.02-1.14)
Two burrs used, n (%)9 (81.8)
Three burrs used, n (%)2 (18.2)
Post-SA stent length, mm29 (18-38)
Stent length implanted, mm29 (23-36)
Stent implantation (post-SA), n (%)9 (81.8)
BMS/DES (stent type), n (%)0/9 (81.8)
Drug-eluting balloon post SA, n (%)2 (18.2)
Scoring/cutting balloon, n (%)8 (72.7)/3 (27.3)
Maximum balloon diameter (post SA), mm3.0 (2.5-3.5)
Final stent diameter, mm3.0 (2.5-3.5)

DES: drug eluting stent; BMS: bare metal stent; ISR: in-stent restenosis; LM: left main artery; LAD: left anterior descending artery; LCX: left circumflex artery; RCA: right coronary artery; SA: stent ablation; MLD: minimum lumen diameter; MLA: minimum lumen area.

New window| CSV


Table 3   Clinical outcomes

ParametersResults
In-hospital death, n (%)0 (0)
Mean follow-up period, months13 (9-20)
Death, n (%)0 (0)
Myocardial infarction, n (%)0 (0)
Target lesion revascularization, n (%)1 (9.1)
Non-target lesion revascularization, n (%)2 (18.2)
Major adverse cardiac events (per patient), n (%)1 (9.1)

New window| CSV


The lower amount of contrast (130 [120-150] mL) and the lower dose of radiation (1,195.0 [998.0-1,356.0] mGy) were used, which reduced renal damage in patients with renal insufficiency, and protect both patients and surgical staff. More burrs (2 [2-3]) were used in our study.

DISCUSSION

In the absence of intracavitary imaging applications, the understanding of coronary artery calcification was very limited. With the clinical application of IVUS or OCT, surgeons can obtain information about the presence, extent, distribution, and calcification eccentricity index of calcified plaques.[13,14,15] Such data can guide the selection of revascularization strategies. However, using the traditional PCI surgical method, the calcified lesions are insufficiently understood and pre-treatment is insufficient. This results in poor expansion of the implanted stent, which leads to ACS due to stenosis or thrombosis and affects the long-term outcome of patients.[16,17,18] Underexpanded stents are often treated with high-pressure non-compliant balloons, scoring balloons, or cutting balloons. However, balloons often cause changes in the shape of the stent steel beam or they are eventually unsuccessful in expanding.[19,20,21] Therefore, in ACS cases with severe calcification and ineffective balloon expansion, SA is often required. Moreover, it is better to perform IVUS for endovascular assessment to guide the internal atherectomy.[22,23,24] IVUS can provide important parameters that are instructive for subsequent treatment strategies, such as specific segments and causes of stent insufficiency, restenosis in whole stent, and MLD. According to the data obtained, the treatment strategy, including the burr size, SA degree, and stent size required, can be correctly selected.

In the ACS case shown in Figure 1, we performed the first-run IVUS examination of the target vessel before SA. The stent size was 3.0 mm×38.0 mm and the MLD of underexpanded stent was 1.8 mm; thus, 1.5 mm was selected for the first burr. After SA, repeated IVUS examinations showed that the MLD increased to 1.91 mm, but there was still serious calcification. The size of the second burr was selected as 2.0 mm. After the second SA, the MLD was 2.31 mm. Then, a 3.0-mm scoring balloon with pressure of 16 atm (1 atm=1.01×105 Pa) was expanded fully and a new stent with 3.0 mm×23 mm was implanted successfully. Finally, the expansion and adherence of the stent as checked by IVUS were satisfactory. Based on our experience, the first burr size is preferably smaller (0.1-0.2 mm) than the MLD (the size of first burr usually 1.25 mm or 1.50 mm), while the size of the second burr tends to be larger (0.1-0.2 mm) than the MLD after the SA. This burr selection principle “downsize first, upsize last” can increase the effect of modification in the first SA and the effect of polishing in the second SA.

Figure 1.

Figure 1.   An ACS case performed with the first-run IVUS examination. A: MLD 1.8-1.9 mm indicated by IVUS; B: after the first SA with a 1.5-mm burr the MLD became significantly larger, but there was still significant calcification and a partial stent; C: an underexpanded stent with significant stenosis; D and E: after the second SA with a 2.0-mm burr, the lesion was treated with scoring balloon expansion and implantation of the stent; ACS: acute coronary syndrome; IVUS: intravascular ultrasound; MLD: minimum lumen diameter; SA: stent ablation.


Limitation

The main limitation of our work was that there were only 11 included patients.

CONCLUSIONS

The main findings of the present study are: (1) SA is a safe and effective strategy in treating underexpanded stent patients with ACS; (2) IVUS used during intervention can reduce the risk of burr entrapment and balloon rupture and increase the success rate of the entire surgical procedure through guiding the selection of stent size and final evaluation of surgical effects; and (3) IVUS can reduce the radiation dose and contrast amount used in the RA procedure. Further analyses in multicenter registries are still required to confirm these findings.

Funding: This work was supported by the Chongqing Health Commission (2016ZDXM024), the Zhejiang Provincial Public Welfare Technology Research Project (LGF20H020012), and the Scientific Research Project of the Department of Education in Zhejiang (Y21330290).

Ethical approval: The Institution Ethics Committee from the Second Affiliated Hospital of Zhejiang University School of Medicine approved the study.

Conflicts of interests: The authors have no conflicts of interest to declare.

Contributors: KC and YQS contributed equally to this work. All authors read and approved the final version of the manuscript.

Reference

Gao R.

Current status of percutaneous coronary intervention in China

Heart. 2010; 96(6):415-8.

DOI:10.1136/hrt.2009.170571      URL     [Cited within: 1]

Cao Q, Shi L, Wang H, Dong K.

Report from China: health insurance in China——evolution, current status, and challenges

Int J Health Serv. 2012; 42(2):177-95.

PMID:22611649      [Cited within: 1]

The authors review the evolution of health insurance in China and analyze how it has been shaped to its current form by political and economic dynamics. They summarize the current status of health insurance in terms of population coverage, benefit design, scope of service, and its interaction with providers; address challenges regarding future health insurance reform; and propose policy recommendations. Although the recent health insurance reform has made major breakthroughs in population coverage, it is still too early to judge whether the political willingness to appease social unrest can be translated into concrete health care protections for the population.

Sugiyama T, Yamamoto E, Fracassi F, Lee H, Yonetsu T, Kakuta T, et al.

Calcified plaques in patients with acute coronary syndromes

JACC Cardiovasc Interv. 2019; 12(6):531-40.

DOI:S1936-8798(18)32482-8      PMID:30898249      [Cited within: 1]

This study conducted detailed analysis of calcified culprit plaques in patients with acute coronary syndromes (ACS).Calcified plaques as an underlying pathology in patients with ACS have not been systematically studied.From 1,241 patients presenting with ACS who had undergone pre-intervention optical coherence tomography imaging, 157 (12.7%) patients were found to have a calcified plaque at the culprit lesion. Calcified plaque was defined as a plaque with superficial calcification at the culprit site without evidence of ruptured lipid plaque.Three distinct types were identified: eruptive calcified nodules, superficial calcific sheet, and calcified protrusion (prevalence of 25.5%, 67.4%, and 7.1%, respectively). Eruptive calcified nodules were frequently located in the right coronary arteries (44.4%), whereas superficial calcific sheet was most frequently found in the left anterior descending coronary arteries (68.4%) (p = 0.012). Calcification index (mean calcification arc × calcification length) was greatest in eruptive calcified nodules, followed by superficial calcific sheet, and smallest in calcified protrusion (median 3,284.9 [interquartile range (IQR): 2,113.3 to 5,385.3] vs. 1,644.3 [IQR: 1,012.4 to 3,058.7] vs. 472.5 [IQR: 176.7 to 865.2]; p < 0.001). The superficial calcific sheet group had the highest peak post-intervention creatine kinase values among the groups (eruptive calcified nodules vs. superficial calcific sheet vs. calcified protrusion: 241 [IQR: 116 to 612] IU/l vs. 834 [IQR: 141 to 3,394] IU/l vs. 745 [IQR: 69 to 1,984] IU/l; p = 0.032).Three distinct types of calcified culprit plaques are identified in patients with ACS. Superficial calcific sheet, which is frequently located in the left anterior descending coronary artery, is the most prevalent type and is also associated with greatest post-intervention myocardial damage. (Identification of Predictors for Coronary Plaque Erosion in Patients With Acute Coronary Syndrome; NCT03479723).Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, et al.

Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions

Circulation. 1995; 91(7):1959-65.

PMID:7895353      [Cited within: 1]

Target lesion calcium is a marker for significant coronary artery disease and a determinant of the success of transcatheter therapy.Eleven hundred fifty-five native vessel target lesions in 1117 patients were studied by intravascular ultrasound (IVUS) and coronary angiography. The presence, magnitude, location, and distribution of IVUS calcium were analyzed and compared with the detection and classification (none/mild, moderate, and severe) by angiography. Angiography detected calcium in 440 of 1155 lesions (38%): 306 (26%) moderate calcium and 134 (12%) severe. IVUS detected lesion calcium in 841 of 1155 (73%, P < .0001 versus angiography). The mean arc of lesion calcium measured 115 +/- 110 degrees; the mean length measured 3.5 +/- 3.7 mm. Target lesion calcium was only superficial in 48%, only deep in 28%, and both superficial and deep in 24%. The mean arc of superficial calcium measured 85 +/- 108 degrees; the mean length measured 2.4 +/- 3.4 mm. Three hundred seventy-three of 1155 reference segments (32%) contained calcium (P < .0001 compared with lesion site). The mean arc of reference calcium measured 42 +/- 80 degrees; the mean length measured 1.7 +/- 3.6 mm. Only 44 (4%) had reference calcium in the absence of lesion calcium. Angiographic detection and classification of calcium depended on arcs, lengths, location, and distribution of lesion and reference segment calcium. By discriminant analysis, the classification function for predicting angiographic calcium included the arc of target lesion calcium, the arc of superficial calcium, the length of reference segment calcium, and the location of calcium within the lesion. This model correctly predicted the angiographic detection of calcification in 74.4% of lesions and the angiographic classification (none/moderate/severe) of calcium in 62.8% of lesions.IVUS detected calcium in > 70% of lesions, significantly more often than standard angiography. Although angiography is moderately sensitive for the detection of extensive lesion calcium (sensitivity, 60% and 85% for three- and four-quadrant calcium, respectively), it is less sensitive for the presence of milder degrees.

Barbato E, Carrié D, Dardas P, Fajadet J, Gaul G, Haude M, et al.

European expert consensus on rotational atherectomy

EuroIntervention. 2015; 11(1):30-6.

DOI:10.4244/EIJV11I1A6      URL     [Cited within: 1]

Eftychiou C, Barmby DS, Wilson SJ, Ubaid S, Markwick AJ, Makri L, et al.

Cardiovascular outcomes following rotational atherectomy: a UK multicentre experience

Catheter Cardiovasc Interv. 2016; 88(4):546-53.

DOI:10.1002/ccd.26587      PMID:27258651      [Cited within: 1]

To identify factors associated with outcomes following rotational atherectomy (RA).RA is an effective way to mechanically modify heavily calcified lesions before stenting; however its outcomes are not well defined.Retrospective evaluation of all patients who underwent RA in three large UK centers (Leeds General Infirmary (LGI), Royal Infirmary of Edinburgh (RIE) and University Hospital of North Staffordshire (UHNS)) from March 2005 to January 2013. Five hundred and eighteen patients had RA with median follow-up period of 22 months. About 68.3% were male, 28.7% had DM and 34.6% were treated because of ACS. Stents were deployed in 97.3% of the patients while 30.7% of the procedures were performed transradially. Maximum burr was ≤1.75 mm in 85.5% and the mean SYNTAX score was 19.5 ± 11.6. Peri-procedural complications occurred in 6.4% and vascular access complications in 1.9%. Outcomes in the follow-up period were: MACE 17.8%, cardiac death 7.1%, MI 11.7%, TVR 7.5%, all-cause death 13.7%, definite stent thrombosis (ST) 1.4% and stroke 2.9%. Patients with intermediate and high SYNTAX scores were more likely to suffer MACE, cardiac death, MI, all-cause death and ST. Patients with a SYNTAX score >32 were also more likely to have a peri-procedural complication. Multiple logistic regression analysis showed that the presence of PVD (P = 0.026, OR = 2.0), DM (P = 0.008, OR = 2.1), ACS presentation (P = 0.011, OR = 2.1) and SYNTAX score ≥23 (P = 0.02, OR = 1.9) had a significant association with MACE.RA is safe and effective, with high rate of procedural success and relatively low incidence of MACE. PVD, DM, ACS presentation and SYNTAX score were significant predictors for MACE. © 2016 Wiley Periodicals, Inc.© 2016 Wiley Periodicals, Inc.

Song HG, Kang SJ, Mintz GS.

Value of intravascular ultrasound in guiding coronary interventions

Echocardiography. 2018; 35(4):520-33.

DOI:10.1111/echo.13837      URL     [Cited within: 1]

Schuurman AS, Vroegindewey MM, Kardys I, Oemrawsingh RM, Garcia-Garcia HM, van Geuns RJ, et al.

Prognostic value of intravascular ultrasound in patients with coronary artery disease

J Am Coll Cardiol. 2018; 72(17):2003-11.

DOI:10.1016/j.jacc.2018.08.2140      URL     [Cited within: 1]

Zhang YJ, Pang S, Chen XY, Bourantas CV, Pan DR, Dong SJ, et al.

Comparison of intravascular ultrasound guided versus angiography guided drug eluting stent implantation: a systematic review and meta-analysis

BMC Cardiovasc Disord. 2015; 15:153.

DOI:10.1186/s12872-015-0144-8      URL     [Cited within: 1]

Gao XF, Wang ZM, Wang F, Gu Y, Ge Z, Kong XQ, et al.

Intravascular ultrasound guidance reduces cardiac death and coronary revascularization in patients undergoing drug-eluting stent implantation: results from a meta-analysis of 9 randomized trials and 4724 patients

Int J Cardiovasc Imaging. 2019; 35(2):239-47.

DOI:10.1007/s10554-019-01555-3      URL     [Cited within: 1]

Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al.

2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease

J Am Coll Cardiol. 2014; 64(18):1929-49.

DOI:10.1016/j.jacc.2014.07.017      URL     [Cited within: 1]

Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al.

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology

Eur Heart J. 2013; 34(38):2949-3003.

DOI:10.1093/eurheartj/eht296      URL     [Cited within: 1]

Iida O, Mano T.

Role of IVUS in the endovascular treatment of calcified femoropopliteal lesions

J Endovascular Ther. 2019; 26(3):331-2.

DOI:10.1177/1526602819838991      URL     [Cited within: 1]

Chen GX, Wang HN, Zou JL, Yuan XX.

Effects of intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction after emergency PCI

World J Emerg Med. 2020; 11(3):157-63.

DOI:10.5847/wjem.j.1920-8642.2020.03.005      URL     [Cited within: 1]

Ali ZA, Karimi Galougahi K, Maehara A, Shlofmitz RA, Ben-Yehuda O, Mintz GS, et al.

Intracoronary optical coherence tomography 2018: current status and future directions

JACC Cardiovasc Interv. 2017; 10(24):2473-87.

DOI:10.1016/j.jcin.2017.09.042      URL     [Cited within: 1]

Devidutta S, Yeo KK.

Acute stent thrombosis due to stent underexpansion managed with rotational atherectomy

Cardiovasc Revasc Med. 2016; 17(1):66-70.

DOI:10.1016/j.carrev.2015.10.003      PMID:26643071      [Cited within: 1]

Stent underexpansion is a well known risk factor for stent thrombosis. We report a case of acute stent thrombosis which occurred after primary percutaneous coronary intervention to the right coronary artery for an inferior ST-elevation myocardial infarction. Minutes after completion of the procedure, the patient had acute stent thrombosis, manifested by new chest pain and new ST-elevation. IVUS showed the stent to be underexpanded. Despite high pressure balloon inflation, the stent remained underexpanded. This was then managed with rotational atherectomy within the underexpanded stent, followed by high-pressure balloon dilatation and deployment of another stent within it. Copyright © 2015 Elsevier Inc. All rights reserved.

Kobayashi Y, Okura H, Kume T, Yamada R, Kobayashi Y, Fukuhara K, et al.

Impact of target lesion coronary calcification on stent expansion

Circ J. 2014; 78(9):2209-14.

DOI:10.1253/circj.CJ-14-0108      URL     [Cited within: 1]

Généreux P, Madhavan MV, Mintz GS, Maehara A, Palmerini T, Lasalle L, et al.

Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. pooled analysis from the horizons-ami (harmonizing outcomes with revascularization and stents in acute myocardial infarction) and acuity (acute catheterization and urgent intervention triage strategy) trials

J Am Coll Cardiol. 2014; 63(18):1845-54.

DOI:10.1016/j.jacc.2014.01.034      URL     [Cited within: 1]

Secco GG, Ghione M, Mattesini A, Dall'Ara G, Ghilencea L, Kilickesmez K, et al.

Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon

EuroIntervention. 2016; 12(3):359-65.

DOI:10.4244/EIJY15M06_04      URL     [Cited within: 1]

Rahel BM, Suttorp MJ, ten Berg JM, Bal ET, Ernst SM, Rensing BJ, et al.

Cutting balloon for in-stent restenosis: acute and long-term results

J Interv Cardiol. 2004; 17(4):197-201.

DOI:10.1111/j.1540-8183.2004.00378.x      URL     [Cited within: 1]

Kufner S, Joner M, Schneider S, Tölg R, Zrenner B, Repp J, et al.

Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents: a randomized controlled trial

JACC Cardiovasc Interv. 2017; 10(13):1332-40.

DOI:10.1016/j.jcin.2017.04.024      URL     [Cited within: 1]

Édes IF, Ruzsa Z, Szabó G, Lux Á, Gellér L, Molnár L, et al.

Rotational atherectomy of undilatable coronary stents: stentablation, a clinical perspective and recommendation

EuroIntervention. 2016; 12(5):e632-5.

DOI:10.4244/EIJV12I5A103      URL     [Cited within: 1]

Hernández-Enríquez M, Campelo-Parada F, Lhermusier T, Bouisset F, Roncalli J, Elbaz M, et al.

Long-term outcomes of rotational atherectomy of underexpanded stents. A single center experience

J Interv Cardiol. 2018; 31(4):465-70.

DOI:10.1111/joic.12491      PMID:29372576      [Cited within: 1]

To analyze the procedural and long-term outcomes of the use of rotational atherectomy (RA) in underexpanded stents in our cohort and to provide an overview of currently available data on this technique.Stent underexpansion (SU) has been related to stent thrombosis and restenosis. RA has been used to treat undilatable SU as a bail-out strategy with encouraging results.This is an observational, single-center study. We included patients who underwent stentablation between 2013 and 2017. Baseline demographics, procedural results, in-hospital major adverse cardiac events (MACE), and long-term follow-up MACE were retrospectively collected.A total of 11 patients (90.9% males, mean age 65.4 ± 18.6) were included in this study. Median left ventricle ejection fraction was 53.5% [46.2-55]. Median calculated Syntax score was 16 [9-31] and 45.5% of patients were admitted for acute coronary syndrome. Radial approach was used in 63.6% of cases. Most patients only required one burr (45% used a 1.5 mm diameter burr) during the intervention. Procedural success was achieved in 90.9% of the cases. Acute lumen gain was 42.7% [30.7-61.49]. There were no in-hospital deaths or MACE. At a median follow-up of 26 months, only one patient (9.1%) suffered MACE in the context of acute coronary syndrome, and two patients (18.2%) required non-target lesion revascularization. No deaths were reported.RA of under expanded stents is a feasible option with a high rate of procedural success. At long-term follow-up, all of them were alive and 90.9% of patients remained free from MACE.© 2018 The Authors. Journal of Interventional Cardiology Published by Wiley Periodicals, Inc.

Ferri LA, Jabbour RJ, Giannini F, Benincasa S, Ancona M, Regazzoli D, et al.

Safety and efficacy of rotational atherectomy for the treatment of undilatable underexpanded stents implanted in calcific lesions

Catheter Cardiovasc Interv. 2017; 90(2):E19-24.

DOI:10.1002/ccd.v90.2      URL     [Cited within: 1]

/